Last reviewed · How we verify

NCT06146322

Barley Beta-glucan, Glycemic Control, and Appetite

Completed NA Last updated 24 November 2023
What this trial tests

NA trial testing WR in Diet, Healthy in 16 participants. Completed in 31 October 2020.

Timeline
1 October 2019
Primary endpoint
31 October 2020
31 October 2020

Quick facts

Lead sponsorWashington State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposeprevention
Enrollment16
Start date1 October 2019
Primary completion31 October 2020
Estimated completion31 October 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Washington State University

Who can join

Adults 18 to 50, any sex, with Diet, Healthy or Blood Sugar; High. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Novel barley varieties high in the soluble fiber β-glucan have the capacity to improve population health through improving glycemic control. Sweetened and unsweetened wholegrain barley foods were tested in a randomized, controlled, crossover human clinical trial to assess impact on postprandial appetite and food intake.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. High β-Glucan Whole Grain Barley Reduces Postprandial Glycemic Response in Healthy Adults-Part One of a Randomized Controlled Trial.
    Kellogg JA, Monsivais P, Murphy KM, Perrigue MM. · · 2025 · cited 4× · PMID 39940286 · DOI 10.3390/nu17030430

Verify or expand the search:

Other recruiting trials for Diet, Healthy

Currently open trials in the same condition.

Other Washington State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06146322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing